Cordycepin Induces Apoptosis and Inhibits Proliferation of Human Lung Cancer Cell Line H1975 via Inhibiting the Phosphorylation of EGFR

Facile and efficient synthesis and biological evaluation of 4-anilinoquinazoline derivatives as EGFR inhibitors

(2016) Zheng Wang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer

(2016) Shuhang Wang et al.   Journal of Hematology & Oncology

EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature

(2016) YANG YANG et al.   Oncology Letters

Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

(2014) Wen-Ling Yao et al.   Anti-Cancer Agents in Medicinal Chemistry

Cordycepin induces apoptosis of C6 glioma cells through the adenosine 2A receptor-p53-caspase-7-PARP pathway

(2014) Ying Chen et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Cordycepin Induces S Phase Arrest and Apoptosis in Human Gallbladder Cancer Cells

(2014) Xu-An Wang et al.   MOLECULES

Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen species-mediated mitochondrial death pathway

(2013) HYE HYEON LEE et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Structure–Activity Relationships of Synthetic Cordycepin Analogues as Experimental Therapeutics for African Trypanosomiasis

(2013) Suman K. Vodnala et al.   JOURNAL OF MEDICINAL CHEMISTRY

Update of epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer

(2013) Yuh-Min Chen   Journal of the Chinese Medical Association

Cordycepin: A bioactive metabolite with therapeutic potential

(2013) Hardeep S. Tuli et al.   LIFE SCIENCES

A novel strategy to the synthesis of 4-anilinoquinazoline derivatives

(2013) Zheng Wang et al.   TETRAHEDRON

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

(2013) A. O. Walter et al.   Cancer Discovery

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

(2011) L. V. Sequist et al.   Science Translational Medicine

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

(2009) Wenjun Zhou et al.   NATURE

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

(2008) C.-H. Yun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA